InvestorsHub Logo

Smokey21

10/04/17 8:02 AM

#137501 RE: biosectinvestor #137493

Biosect, the company has spoken of what they believe to be an extremely large naked short position. For those of us that have spoken to Les on a regular basis, it is something that always comes up somewhere in the conversation. Watching the stock action literally all day for 3+ years, I can tell you, there is no way the number of shares that have been sold and the pattern in which they are sold (particularly the way NITE works) is engineered to bring the company down, at any cost. I think they underestimated the fortitude and commitment of retail on this one. We have held and continued to buy all the way down. In the end, either we are the biggest fools, or the biggest winners. Like Linda, many of us are prepared to "go big, or go home".

Patiently waiting, and hoping to see the shorts burn in a VW like squeeze as they try to cover their naked positions while funds try to get in, and longs like me just hold our shares waiting for the company to realize its true value.

longfellow95

10/04/17 9:36 AM

#137510 RE: biosectinvestor #137493

I've been stalking the stock for more than a year and in it for some time now, initially small amounts and now a good amount of shares, and I've never heard the company mention short sellers. This is a discussion that shareholders are carrying on.



Agree with much of your sentiment in your posts today.
Though on the point above, the company has previously referred to short sellers. They are well aware of the pattern back in 2014 and 2015 of whenever the stock was on an upward trend, AF would do a hit piece, and that would be rapidly followed by a round of short-selling, which would depress the price. Buzdargate was only one of many examples.

In their 19 Oct 2015 PR, NWBO stated in the subheading:-

Reiterates Encouraging Clinical Data;
Sees Coordinated Shorting Campaign



And went on to say:-

NW Bio noted that the Company’s shares have experienced highly unusual trading activity since the September release of positive data, including especially on Friday, October 16, when more than 2.9 million NW Bio shares were traded, representing five times its recent average daily trading volume. The Company believes this activity is part of an ongoing effort to drive its stock price lower through an orchestrated campaign, including questionable short selling activity. The Company is intensifying its investigation and gathering of evidence.



https://www.nwbio.com/nw-bio-issues-statement-on-highly-unusual-trading-activity/



You're right, however, that in the past 18 months or so, they have elected to remain largely silent on the issue. This follows the appointing of Cofer Black and the setting up of the Investigation.

The radio silence is of course a questionable strategy; look where it's got them. I can only surmise that they justify it to themselves, because in the bitter end, there will be an almighty reckoning and come-uppance for the naked short conspirators, (the wolf pack, if you prefer.)

I'd encourage you to look back to that 2014/15 period to see just how much they were under relentless attack.

The article by Steve Pearlstein is worth seeing if you haven't already:-
https://www.washingtonpost.com/business/northwest-biotherapeutics-stock-woes-highlight-the-harm-of-short-sales/2014/09/26/78b99b0a-4507-11e4-b47c-f5889e061e5f_story.html?utm_term=.37cdfc2ffdbc

Of course, NWBO's silence has been matched by a total embargo on NWBO by all the big media companies (except for occasional attacks from Murdoch owned The Times), which tends to reinforce the view regarding a possible high level conspiracy.
Hence the rather surreal situation currently where the company receives virtually zero coverage (except SoS bless him) and only gives out minimum statutory reporting itself.

Things might have been very different if NW had remained on board, because his level of financial clout was a threat to the most determined shorts. That was when Phase V report came out and was followed by a further raft of lawsuits.